Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling

Circ Res. 2003 Mar 21;92(5):e52-9. doi: 10.1161/01.RES.0000064585.95749.6D. Epub 2003 Mar 6.

Abstract

A neuronal isoform of nitric oxide synthase (nNOS) has recently been located to the cardiac sarcoplasmic reticulum (SR). Subcellular localization of a constitutive NOS in the proximity of an activating source of Ca2+ suggests that cardiac nNOS-derived NO may regulate contraction by exerting a highly specific and localized action on ion channels/transporters involved in Ca2+ cycling. To test this hypothesis, we have investigated myocardial Ca2+ handling and contractility in nNOS knockout mice (nNOS-/-) and in control mice (C) after acute nNOS inhibition with 100 micromol/L L-VNIO. nNOS gene disruption or L-VNIO increased basal contraction both in left ventricular (LV) myocytes (steady-state cell shortening 10.3+/-0.6% in nNOS-/- versus 8.1+/-0.5% in C; P<0.05) and in vivo (LV ejection fraction 53.5+/-2.7 in nNOS-/- versus 44.9+/-1.5% in C; P<0.05). nNOS disruption increased ICa density (in pA/pF, at 0 mV, -11.4+/-0.5 in nNOS-/- versus -9.1+/-0.5 in C; P<0.05) and prolonged the slow time constant of inactivation of ICa by 38% (P<0.05), leading to an increased Ca2+ influx and a greater SR load in nNOS-/- myocytes (in pC/pF, 0.78+/-0.04 in nNOS-/- versus 0.64+/-0.03 in C; P<0.05). Consistent with these data, [Ca2+]i transient (indo-1) peak amplitude was greater in nNOS-/- myocytes (410/495 ratio 0.34+/-0.01 in nNOS-/- versus 0.31+/-0.01 in C; P<0.05). These findings have uncovered a novel mechanism by which intracellular Ca2+ is regulated in LV myocytes and indicate that nNOS is an important determinant of basal contractility in the mammalian myocardium. The full text of this article is available at http://www.circresaha.org.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / analysis
  • Calcium / metabolism*
  • Calcium Channels / physiology
  • Electric Conductivity
  • Enzyme Inhibitors / pharmacology
  • Heart Ventricles / cytology
  • Heart Ventricles / enzymology
  • Mice
  • Mice, Knockout
  • Myocardial Contraction*
  • Myocardium / enzymology
  • Myocardium / metabolism
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / enzymology*
  • Myocytes, Cardiac / physiology*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / genetics
  • Nitric Oxide Synthase / physiology*
  • Nitric Oxide Synthase Type I
  • Ornithine / analogs & derivatives*
  • Ornithine / pharmacology
  • Patch-Clamp Techniques
  • Sarcoplasmic Reticulum / chemistry
  • Sarcoplasmic Reticulum / enzymology
  • Ventricular Function

Substances

  • Calcium Channels
  • Enzyme Inhibitors
  • N(5)-(1-imino-3-butenyl)ornithine
  • Ornithine
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type I
  • Nos1 protein, mouse
  • Calcium